Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Grail Inc (GRAL)

Grail Inc (GRAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,950,911
  • Shares Outstanding, K 41,020
  • Annual Sales, $ 147,170 K
  • Annual Income, $ -408,350 K
  • EBIT $ -534 M
  • EBITDA $ -371 M
  • 60-Month Beta 4.62
  • Price/Sales 14.15
  • Price/Cash Flow N/A
  • Price/Book 0.77

Options Overview Details

View History
  • Implied Volatility 93.04% (-5.05%)
  • Historical Volatility 71.13%
  • IV Percentile 48%
  • IV Rank 42.89%
  • IV High 127.59% on 04/21/25
  • IV Low 67.09% on 09/04/25
  • Expected Move (DTE 6) 3.83 (8.40%)
  • Put/Call Vol Ratio 1.99
  • Today's Volume 1,568
  • Volume Avg (30-Day) 823
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 27,826
  • Open Int (30-Day) 30,115
  • Expected Range 41.80 to 49.46

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-2.92
  • Number of Estimates 1
  • High Estimate $-2.92
  • Low Estimate $-2.92
  • Prior Year $-3.10
  • Growth Rate Est. (year over year) +5.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.53 +9.87%
on 03/13/26
55.36 -17.58%
on 04/01/26
-3.04 (-6.25%)
since 03/10/26
3-Month
41.50 +9.95%
on 02/23/26
118.84 -61.60%
on 01/22/26
-54.47 (-54.42%)
since 01/09/26
52-Week
22.30 +104.62%
on 04/11/25
118.84 -61.60%
on 01/22/26
+22.88 (+100.57%)
since 04/10/25

Most Recent Stories

More News
GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide

Integration Will Enable Approximately 450 Health Systems to Access the Galleri Test Results Within Their Existing Patient Portal

GRAL : 45.63 (-4.06%)
GRAL Investors Have Opportunity to Join GRAIL, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of GRAIL, Inc. (“GRAIL” or “the Company”) (NASDAQ:...

GRAL : 45.63 (-4.06%)
Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection

Partnership expands access to breakthrough blood-based cancer screening into Superpower's comprehensive health check and personalized plans.

GRAL : 45.63 (-4.06%)
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES

Grail told investors cash burn would be no more than $290 million while guiding to milestones the Company may have known were at risk

GRAL : 45.63 (-4.06%)
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES

Grail told investors cash burn would be no more than $290 million while guiding to milestones the Company may have known were at risk

GRAL : 45.63 (-4.06%)
Stocks Sharply Lower on Iran War and Hawkish Powell

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -1.36%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.43%. March...

MSTR : 128.64 (-0.17%)
GOOGL : 317.24 (-0.39%)
AAPL : 260.48 (unch)
HL : 19.46 (+0.83%)
CDE : 20.24 (+2.64%)
GLXY : 21.66 (+2.41%)
LITE : 897.30 (+0.35%)
COIN : 167.85 (-0.69%)
TSLA : 348.95 (+0.96%)
SBUX : 96.60 (-0.33%)
SCCO : 192.56 (+2.40%)
^BTCUSD : 72,712.54 (-0.93%)
Following the Fed's Rate Decision, the S&P 500 and Dow Fall to New Closing Lows for 2026

The S&P 500 Index ($SPX ) (SPY ) and the Dow Jones Industrial Average ($DOWI ) (DIA ) both fell to new 2026 closing lows today. The S&P 500 dropped 1.36% while the Dow tumbled 1.63% by the market close....

MSTR : 128.64 (-0.17%)
B : 43.55 (+2.64%)
HL : 19.46 (+0.83%)
DHI : 142.64 (-0.77%)
CDE : 20.24 (+2.64%)
TTD : 20.09 (-2.52%)
GLXY : 21.66 (+2.41%)
BLDR : 85.30 (+0.11%)
RKLB : 68.05 (+1.96%)
$IUXX : 25,116.34 (+0.14%)
LITE : 897.30 (+0.35%)
M : 18.86 (-1.46%)
Stocks Fall as US PPI Jumps and Iran War Escalates

The S&P 500 Index ($SPX ) (SPY ) today is down -0.24%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.34%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.21%. March E-mini S&P futures...

B : 43.55 (+2.64%)
HL : 19.46 (+0.83%)
CDE : 20.24 (+2.64%)
TTD : 20.09 (-2.52%)
RKLB : 68.05 (+1.96%)
$IUXX : 25,116.34 (+0.14%)
LITE : 897.30 (+0.35%)
ZNM26 : 111-030s (-0.13%)
GLW : 171.24 (+0.85%)
ESM26 : 6,855.25s (-0.12%)
STX : 503.13 (+0.47%)
WDC : 343.43 (+1.64%)
GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor

MENLO PARK, Calif. , March 12, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that Bob Ragusa...

GRAL : 45.63 (-4.06%)
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES

Grail told investors cash burn would be no more than $290 million while guiding to milestones the Company may have known were at risk

GRAL : 45.63 (-4.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

GRAIL LLC is a biotechnology company. It focuses on developing technologies for early cancer detection. GRAIL LLC is based in Menlo Park, United States.

See More

Key Turning Points

3rd Resistance Point 51.46
2nd Resistance Point 49.66
1st Resistance Point 47.65
Last Price 45.63
1st Support Level 43.84
2nd Support Level 42.04
3rd Support Level 40.03

See More

52-Week High 118.84
Fibonacci 61.8% 81.96
Fibonacci 50% 70.57
Fibonacci 38.2% 59.18
Last Price 45.63
52-Week Low 22.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.